v3.22.2.2
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY
¥ in Thousands, $ in Thousands
Class A Ordinary Shares
Common Stock [Member]
CNY (¥)
shares
Class C Ordinary Shares
Common Stock [Member]
CNY (¥)
shares
Additional paid-in capital [Member]
CNY (¥)
Statutory reserves [Member]
CNY (¥)
Retained Earnings (Accumulated deficit) [Member]
CNY (¥)
Accumulated other comprehensive income [Member]
CNY (¥)
Non-controlling Interest [Member]
CNY (¥)
USD ($)
CNY (¥)
Balance at Dec. 31, 2020 ¥ 794 ¥ 90 ¥ 3,545,073 ¥ 4,210 ¥ (3,419,146) ¥ 12,101 ¥ (1,968)   ¥ 141,154
Balance (in shares) at Dec. 31, 2020 | shares 41,923,276 4,708,415              
Increase (Decrease) in Shareholders' Equity                  
Share-based compensation     219           219
Issuance of ordinary shares for restricted stock award ¥ 0   0            
Issuance of ordinary shares for restricted stock award (in shares) | shares 12,500                
Foreign currency translation adjustment           115     115
Unrealized gain on investment, net of income taxes           38     38
Net income (loss)         (14,329)   (242)   (14,571)
Balance at Mar. 31, 2021 ¥ 794 ¥ 90 3,545,292 4,210 (3,433,475) 12,254 (2,210)   126,955
Balance (in shares) at Mar. 31, 2021 | shares 41,935,776 4,708,415              
Balance at Dec. 31, 2020 ¥ 794 ¥ 90 3,545,073 4,210 (3,419,146) 12,101 (1,968)   141,154
Balance (in shares) at Dec. 31, 2020 | shares 41,923,276 4,708,415              
Increase (Decrease) in Shareholders' Equity                  
Net income (loss)                 7,592
Balance at Jun. 30, 2021 ¥ 794 ¥ 90 3,545,512 4,210 (3,411,035) 11,907 (2,487)   148,991
Balance (in shares) at Jun. 30, 2021 | shares 41,948,276 4,708,415              
Balance at Mar. 31, 2021 ¥ 794 ¥ 90 3,545,292 4,210 (3,433,475) 12,254 (2,210)   126,955
Balance (in shares) at Mar. 31, 2021 | shares 41,935,776 4,708,415              
Increase (Decrease) in Shareholders' Equity                  
Share-based compensation     220           220
Issuance of ordinary shares for restricted stock award ¥ 0   0            
Issuance of ordinary shares for restricted stock award (in shares) | shares 12,500                
Foreign currency translation adjustment           (532)     (532)
Unrealized gain on investment, net of income taxes           185     185
Net income (loss)         22,440   (277)   22,163
Balance at Jun. 30, 2021 ¥ 794 ¥ 90 3,545,512 4,210 (3,411,035) 11,907 (2,487)   148,991
Balance (in shares) at Jun. 30, 2021 | shares 41,948,276 4,708,415              
Balance at Dec. 31, 2021 ¥ 795 ¥ 90 3,545,955 3,837 (3,415,771) 11,291 485   146,682
Balance (in shares) at Dec. 31, 2021 | shares 41,973,276 4,708,415              
Increase (Decrease) in Shareholders' Equity                  
Share-based compensation     214           214
Issuance of ordinary shares for restricted stock award ¥ 0   0            
Issuance of ordinary shares for restricted stock award (in shares) | shares 12,500                
Foreign currency translation adjustment           (495)     (495)
Unrealized gain on investment, net of income taxes           273     273
Capital injection from non-controlling shareholders             101   101
Net income (loss)         (17,570)   (299)   (17,869)
Balance at Mar. 31, 2022 ¥ 795 ¥ 90 3,546,169 3,837 (3,433,341) 11,069 287   128,906
Balance (in shares) at Mar. 31, 2022 | shares 41,985,776 4,708,415              
Balance at Dec. 31, 2021 ¥ 795 ¥ 90 3,545,955 3,837 (3,415,771) 11,291 485   146,682
Balance (in shares) at Dec. 31, 2021 | shares 41,973,276 4,708,415              
Increase (Decrease) in Shareholders' Equity                  
Net income (loss)               $ (13,465) (90,185)
Balance at Jun. 30, 2022 ¥ 902 ¥ 90 3,553,000 3,837 (3,504,789) 10,035 114 9,434 63,189
Balance (in shares) at Jun. 30, 2022 | shares 47,398,276 4,708,415              
Balance at Mar. 31, 2022 ¥ 795 ¥ 90 3,546,169 3,837 (3,433,341) 11,069 287   128,906
Balance (in shares) at Mar. 31, 2022 | shares 41,985,776 4,708,415              
Increase (Decrease) in Shareholders' Equity                  
Share-based compensation     226           226
Issuance of ordinary shares for restricted stock award ¥ 107   6,605           6,712
Issuance of ordinary shares for restricted stock award (in shares) | shares 5,412,500                
Foreign currency translation adjustment           (584)     (584)
Reversal of unrealized gain on investment, net of income taxes           (450)     (450)
Disposal of subsidiaries             645   645
Capital injection from non-controlling shareholders             50   50
Net income (loss)         (71,448)   (868) (10,797) (72,316)
Balance at Jun. 30, 2022 ¥ 902 ¥ 90 ¥ 3,553,000 ¥ 3,837 ¥ (3,504,789) ¥ 10,035 ¥ 114 $ 9,434 ¥ 63,189
Balance (in shares) at Jun. 30, 2022 | shares 47,398,276 4,708,415